Bringing LSPR Nanotechnology to In Vitro Diagnostics and Life Sciences

LamdaGen has developed a digital LSPR nanotechnology detection platform that enables diagnostic sensitivities and precise quantitation at levels far beyond the expected. Our patented nano-structured Localized Surface Plasmon Resonance technology (LSPR nanotechnology) produces highly robust biosensors in the form of metallic thin films that exhibit remarkable diagnostic detection capabilities into the low femtomolar range.

LamdaGen’s Plasmonic Platform technologies facilitate diagnostic detection limits into the low femtomolar range, multiple logs more sensitive than conventional ELISA.

LSPR v SPR video thumbnail

Click on the image to view a video explaining differences of LSPR and traditional SPR

Diagnostic multi-panel fluidic LSPR chip

Enabling ultra-sensitive, rapid and precisely quantitative In Vitro Diagnostics

Troponin I (cTnI) Ap Note: Read More ›

Platform for Next Generation Diagnostics: Read More ›


Plasmonic ELISA™

Ideally suited for In-Vitro and POC diagnostic systems, LamdaGen’s Plasmonic ELISA platform is precise, highly sensitive and rapid.

Learn More ›

LightPath™ S4

LamdaGen’s LightPath S4 system performs highly sensitive label-free, real-time monitoring and characterization of biomolecular interactions.

Learn More ›

LSPR Biosensors

LamdaGen’s metallic thin-film LSPR-based Optical Biosensors for research and development in the areas of Life Science and Cleantech.

Learn More ›

News & Literature

LamdaGen Corporation Receives Notice of Allowance to Grant European Patent for Enzymatic Assays Performed on LSPR Based Plasmonic Nano-Sensors Read More ...

LamdaGen Corporation Launches Taiwan Diagnostic Subsidiary Read More ...

ACS Nano Publication: Cellular Functional Immunoanalysis Using LamdaGen LSPR Biosensors Read More ...

Abaxis and LamdaGen Corporation Enter Into R&D Diagnostic Collaboration Read More ...

More News >